The designer cytokine IC7Fc attenuates atherosclerosis development by targeting hyperlipidemia in mice

By afschroeder • October 25, 2025

In Het Panhuis W, Thiemann E, van Dijk DMAH, Been B, Jarrett KE, Meurs A, Kooijman S, Hovingh MV, Modder M, van Os BW, Sluiter TJ, Blomberg N, Pronk ACM, Afkir S, Streefland TCM, Lalai RA, Taveras MO, Zhang S, Adams TE, Terry LV, Turpin-Nolan SM, de Vries MR, Giera M, Rose-John S, Zelcer N, de Boer JF, de Aguiar Vallim TQ, Febbraio MA, Rensen PCN, Schönke M. The designer cytokine IC7Fc attenuates atherosclerosis development by targeting hyperlipidemia in mice. Sci Adv. 2025 Oct 24;11(43):eadx3794. doi: 10.1126/sciadv.adx3794. Epub 2025 Oct 24. PMID: 41134879; PMCID: PMC12551718.

Tags: Cardiology/Epi, Publications

Influence of proton pump inhibitors on the incidence and clinical course of oesophageal fistula following catheter ablation for atrial fibrillation: a subanalysis of the POTTER-AF study

Beiert T, Knappe V, Zietzer A, Schmidt V, Pürerfellner H, Sommer P, Sohns C, Veltmann C, Steven D, Chun KJ, Maury P, Gandjbakhch E, Laredo[...]

Case-control study of autonomic symptoms in the setting of Long COVID with tilt table testing

Durstenfeld MS, Mataraarachchi N, Peluso MJ, Levkova-Clark M, Schaffer V, Fehrman EA, Anderson G, Flores D, Henrich TJ, Long CS, Deeks SG, Hsue PY. Case-control[...]

New-Onset Atrial Fibrillation as a Predictor of Cancer: Insights from a Real-World Dataset

Alzahrani A, Gokul K, Paleri A, Powers EM, Bailin S, Yang EH, Fradley M, Farjo P, Dominic P. New-Onset Atrial Fibrillation as a Predictor of[...]